TY - JOUR
T1 - Effects of high-speed rotational atherectomy in peripheral artery disease patients with calcified lesions
T2 - a retrospective multicenter registry
AU - Yamamoto, Yoshiya
AU - Kawarada, Osami
AU - Ando, Hiroshi
AU - Anzai, Hitoshi
AU - Zen, Kan
AU - Tamura, Kenji
AU - Tsukahara, Kengo
AU - Tsubakimoto, Yoshinori
AU - Toma, Masanao
AU - Nakamura, Shigeru
AU - Nakamura, Hiroaki
AU - Hozawa, Koji
AU - Yokoi, Yoshiaki
AU - Yasuda, Satoshi
N1 - Funding Information:
This study was partially supported by Endovascular Asia, a nonprofit physician education and research meeting.
Publisher Copyright:
© 2020, Japanese Association of Cardiovascular Intervention and Therapeutics.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Calcified lesions still remain a technical challenge even in the treatment of infrainguinal artery disease. The aim of this retrospective, multicenter observational study was to investigate interventional outcomes of a high-speed rotational atherectomy device (Rotablator™) and to compare clinical outcomes in patients who underwent Rotablator and those who did not even after failed balloon angioplasty because of underlying calcified lesions. This study enrolled patients who underwent Rotablator (Rota group) and those who did not (Non-rota group) between January 2010 and 2014 December at 12 hospitals. A total of 67 limbs and 68 lesions in 65 patients were included (Rota group; 54 limbs and 55 lesions in 52 patients, Non-rota group; 13 limbs and 13 lesions in 13 patients). In the Rota group, a technical success rate was 94.5% with a complication rate of 1.8%, and all lesions underwent subsequent postdilatation following the adjunctive use of Rotablator, and approximately half of above-the-knee lesions underwent stent implantation. The Rota group had a significantly lower clinically driven reintervention rate at 12 months than the Non-rota group (26.5% vs. 58.3%, respectively, p = 0.046). In addition, Rota group showed a trend toward a higher amputation-free survival compared to the Non-rota group at 1 month (Rota; 98.0% vs. Non-rota; 84.6%, respectively, p = 0.10). Rotablator was used as an adjunctive device with a high technical success and a low complication rates, and Patients who underwent Rotablator yielded a significantly lower clinically driven reintervention rate at 12 months compared to those who did not even after failed balloon angioplasty.
AB - Calcified lesions still remain a technical challenge even in the treatment of infrainguinal artery disease. The aim of this retrospective, multicenter observational study was to investigate interventional outcomes of a high-speed rotational atherectomy device (Rotablator™) and to compare clinical outcomes in patients who underwent Rotablator and those who did not even after failed balloon angioplasty because of underlying calcified lesions. This study enrolled patients who underwent Rotablator (Rota group) and those who did not (Non-rota group) between January 2010 and 2014 December at 12 hospitals. A total of 67 limbs and 68 lesions in 65 patients were included (Rota group; 54 limbs and 55 lesions in 52 patients, Non-rota group; 13 limbs and 13 lesions in 13 patients). In the Rota group, a technical success rate was 94.5% with a complication rate of 1.8%, and all lesions underwent subsequent postdilatation following the adjunctive use of Rotablator, and approximately half of above-the-knee lesions underwent stent implantation. The Rota group had a significantly lower clinically driven reintervention rate at 12 months than the Non-rota group (26.5% vs. 58.3%, respectively, p = 0.046). In addition, Rota group showed a trend toward a higher amputation-free survival compared to the Non-rota group at 1 month (Rota; 98.0% vs. Non-rota; 84.6%, respectively, p = 0.10). Rotablator was used as an adjunctive device with a high technical success and a low complication rates, and Patients who underwent Rotablator yielded a significantly lower clinically driven reintervention rate at 12 months compared to those who did not even after failed balloon angioplasty.
KW - Calcification
KW - Peripheral artery disease
KW - Rotablator
UR - http://www.scopus.com/inward/record.url?scp=85080987669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080987669&partnerID=8YFLogxK
U2 - 10.1007/s12928-020-00643-9
DO - 10.1007/s12928-020-00643-9
M3 - Article
C2 - 32112238
AN - SCOPUS:85080987669
SN - 1868-4300
VL - 35
SP - 393
EP - 397
JO - Cardiovascular Intervention and Therapeutics
JF - Cardiovascular Intervention and Therapeutics
IS - 4
ER -